Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Shin Nippon Biomedical Laboratories, Ltd. ( (JP:2395) ) is now available.
Shin Nippon Biomedical Laboratories, Ltd. reported its consolidated financial results for the six months ended September 30, 2025, showing an 18.1% increase in revenue compared to the previous year. Despite the revenue growth, the company experienced a decline in operating profit and profit attributable to owners of the parent, indicating challenges in maintaining profitability amidst rising revenues.
The most recent analyst rating on (JP:2395) stock is a Hold with a Yen1541.00 price target. To see the full list of analyst forecasts on Shin Nippon Biomedical Laboratories, Ltd. stock, see the JP:2395 Stock Forecast page.
More about Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd. operates in the biomedical industry, focusing on providing laboratory services and solutions. The company is listed on the Prime Market of the Tokyo Stock Exchange and is involved in various aspects of biomedical research and development.
Average Trading Volume: 201,678
Technical Sentiment Signal: Sell
Current Market Cap: Yen61.57B
Find detailed analytics on 2395 stock on TipRanks’ Stock Analysis page.